Slide 1: Investor Deck – Q2 FY25
Nov 27, 2024 Investor Deck – Q2 FY25
Slide 2: Safe Harbour
Safe Harbour Certain statements in this release concerning Sagility’ future growth prospects may be seen as forward- looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. Sagility does not undertake to update any
Slide 3: We are one of the largest pure-play Healthcare Services and Solutions provider
We are one of the largest pure-play Healthcare Services and Solutions provider Broad and deep domain expertise Service Portfolio Tech-led & Transformative in medical, pharmacy, and dental Insurance business Covers payer and provider value chain inclusive of Applications, point solutions, RPA, Analyt
Slide 4: US Healthcare spending is highest among the leading economies and is expected to continue increasing
US Healthcare spending is highest among the leading economies and is expected to continue increasing US Healthcare Expenditure to reach 18.2% US is the Highest Healthcare Spender US Healthcare Outsourcing Potential of US GDP by 2028 among Leading Economies Health expenditure as % of US GDP at curren
Slide 5: Sagility exhibits end-to-end coverage across Payer and Provider space
Sagility exhibits end-to-end coverage across Payer and Provider space… Claims Payment Clinical Revenue Cycle Management Integrity Management Others Management Chronic & Complex Case Intake, Indexing and Imaging Pre-Pay Enrolment Patient Engagement Services Management Adjudication Post-Pay Utilizatio
Slide 6: Offering domain-led and digitally-enabled solutions
…Offering domain-led and digitally-enabled solutions Healthcare Domain-Led Solutions Digitally-Enabled Solutions 1 2 3 4 5 Specialized High-Impact Functional Products & Process Optimization Integrated Tech-Led Digital Services End-to-End Program Services & Transformation Solutions (BPaaS) ✓ Building
Slide 7: Multiple GenAI Case studies across the enterprise
Multiple GenAI Case studies across the enterprise BirchAI’s proprietary technology uses Healthcare specific models from Speech-To-Text to LLMs • Pre-Agent (Automate): Routine calls resolved without human agent involvement • G&A Optimization: Identifies appeals automatically to help resolve faster •
Slide 8: Focused growth strategy anchored on deepening existing relationships, winning new clients, expanding tech capabilities and acquisitions
Focused growth strategy anchored on deepening existing relationships, winning new clients, expanding tech capabilities and acquisitions Identify suitable targets, and effectively evaluate and execute potential opportunities Using analytics and tools for process optimization and efficiency ⚫ Pursue a
Slide 9: Key Highlights
Key Highlights Q2 FY25 Highlights H1 FY25 Highlights ► Revenue in Q2 at ₹13,250 million, grew by ₹2,309 million Y-o-Y ► Revenue in H1 at ₹ 25,484 million grew by ₹3,382 million Y-o-Y (corresponding to 21.1% growth Y-o-Y ) (corresponding to 15.3% growth Y-o-Y ) ► Adjusted EBITDA at ₹3,378 million, gr
Slide 10: KPIs
KPIs KPI Q2 FY25 Q1 FY25 Q2 FY24 Y-o-Y % H1'25 H1'24 Y-o-Y % Revenue from Operation (in INR Million) 13,250 12,233 10,941 21.1% 25,484 22,102 15.3% Revenue by Vertical split By Payer (in INR Million) 11,824 10,901 9,788 20.8% 22,725 19,773 14.9% By Provider (in INR Million) 1,426 1,332 1,153 23.7% 2
Slide 11: Financial Highlights
XS sagility: Financial Highlights
Slide 12: Highlights
Highlights Strong Q2 and H1 FY25 Performance Q2 FY25 Financial Highlights H1 FY25 Financial Highlights ► Q2 FY25 revenue stood at ₹13,250 Million ($157.9 M) ► H1 FY25 revenue stood at ₹25,484 Million ($304.5 M) ► 21.1% growth Y-o-Y (19.8% at constant currency ) ► 15.3% growth Y-o-Y (13.8% at constan
Slide 13: Financial performance snapshot – Q2 FY25
Financial performance snapshot – Q2 FY25 Revenue Y-o-Y Q-o-Q Adjusted EBITDA Y-o-Y Q-o-Q Adjusted PAT Y-o-Y Q-o-Q (INR Million) 21.1% 8.3% (INR Million) 22.2% 6.9% (INR Million) 30.5% 13.1% ₹13,250 ₹3,378 ₹1,636 ₹12,233 ₹3,160 ₹10,941 ₹2,763 ₹1,447 ₹1,254 Q2'24 Q1'25 Q2'25 Q2'24 Q1'25 Q2'25 Q2'24 Q1
Slide 14: Financial performance snapshot – Long Term
Financial performance snapshot – Long Term Revenue FY24 Y-o-Y H1’25 Y-o-Y Adjusted EBITDA FY24 Y-o-Y H1’25 Y-o-Y Adjusted PAT FY24 Y-o-Y H1’25 Y-o-Y (INR Million) 12.7% 15.3% (INR Million) 12.1% 12.8% (INR Million) 29.4% 15.1% ₹47,536 ₹42,184 ₹11,715 ₹5,896 ₹10,449 ₹4,556 ₹25,484 ₹22,102 ₹6,538 ₹5,7
Slide 15: Financial Indicators
Financial Indicators Adjusted EPS (in INR) Adjusted ROCE 1.38 1.43 47.0% 1.06 45.1% 41.6% FY23 FY24 TTM Sep24 FY23 FY24 TTM Sep24 Net Debt Cash Conversion (%) 113.8% ₹22,863 ₹21,678 101.1% 82.0% 87.2% 2.19x 68.2% 70.8% 1.85x ₹9,736 0.78x FY23 FY24 H1 FY 25 Mar-23 Mar-24 TTM Sep24 OCF FCF Net Debt (I
Slide 16: Q2 & H1 FY25 Consolidated Financials
Q2 & H1 FY25 Consolidated Financials Amt in INR M Particulars Q2'25 Q1'25 Q2'24 QoQ% YoY% H1'25 H1'24 YoY% Revenue from Operation 13,250 12,233 10,941 8.3% 21.1% 25,484 22,102 15.3% Other Income 153 244 291 189 405 Employee benefits expense 8,124 8,504 6,805 16,628 13,399 Other expenses 2,115 1,790
Slide 17: Adjustments on EBITDA and PAT
Adjustments on EBITDA and PAT Adj EBITDA Bridge: Q2 FY25 Adj EBITDA Bridge: H1 FY25 INR Million INR Million Reported Adjusted Reported Adj A Adj B Adjusted Adj A Adj B EBITDA EBITDA EBITDA EBITDA Adj PAT Bridge: Q2 FY25 Adj PAT Bridge: H1 FY25 INR Million INR Million Reported Adj A Adj B Adj C Adjus
Slide 18: Go Forward Positions
Go Forward Positions Amt in INR Million Particulars FY'25 FY'26 FY'27 FY'28 FY'29 Closing Debt position 8,020 5,670 - - - Debt Repayment 2,490 2,350 5,670 Interest Payment 746 535 285 Share based payment awards 1,088 215 131 71 34 Earnouts Cost - DCI / Birch 479 343 - - - Intangibles Amortisation 1,
Slide 19: Balance Sheet
Balance Sheet Amt in INR Million Particulars Sep'24 Mar'24 Property, plant and equipment 3,869 3,832 Capital-work-in-progress - 57 Right-of-use assets 5,244 5,665 Goodwill 57,088 57,096 Other intangible assets 19,365 20,078 Trade receivables 10,578 11,813 Cash and cash equivalents 5,068 3,441 Deferr
Slide 20: Consolidated Cash Flow – H1 FY25
Consolidated Cash Flow – H1 FY25 Amt in INR Million Particulars H1'25 FY'24 Profit before tax for the period/ year 2,314 2,417 Adjustment for Non-Operating and Non-Cash 4,033 8,693 Adjustment for working capital 522 (114) Income taxes paid (net of refunds) (781) (1,263) Net cash flows generated from
Slide 21: Thank You
Thank You